Roughly 40 men were lined up in the stairs of Stephenson Hall on Monday afternoon. With backpacks in tow and papers clutched ...

Sunday night saw the remaining couples and their pro partners take part in Dedicated Dance Week, but only one pair had the ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Sickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as haemoglobin S. Sickle cell disease changes the shape of blood cells into a crescent ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

Members of the Indiana General Assembly are urged to address the challenges faced by people with sickle cell disease, highlighting the need for expanded medical coverage.

(HealthDay News) — Adults with sickle cell anemia (SCA) and healthy controls with greater economic deprivation have older brain age, according to a study published online Jan. 17 in JAMA Network Open.

VA lawmakers are considering a proposed bill that could boost funding for research and care related to sickle cell disease, which affects nearly 100,000 Americans — predominantly African Americans.

A sickle cell disease “cure” is to be offered to NHS patients for the first time. The £1.65 million gene therapy called exa-cel, also known under the brand name Casgevy, uses a Nobel Prize ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

The UK’s national health service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care Excellence (NICE) said on Friday.